Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial

References

• AngstJAngstFGerber-WerderRSuicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years’ follow-upArch Suicide Res2005927930016020171
   PubMedGoogle Scholar
• [APA] American Psychiatric AssociationPractice guideline for the treatment of patients with bipolar disorder (revision)Am J Psychiatry2002159150
   Web of Science ®Google Scholar
• [APA] American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders2000Washington DCAPA
   Google Scholar
• BarnesTRA rating scale for drug-induced akathisiaBr J Psychiatry198915467262574607
   PubMed Web of Science ®Google Scholar
• BowdenCLAtypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorderJ Clin Psychiatry200566Suppl 312915762830
   PubMed Web of Science ®Google Scholar
• CartaMZairoFMellinoGAn open label follow-up study on amisulpride in the add-on treatment of bipolar I patientsClin Pract Epidemol Ment Health200621916930471
   PubMedGoogle Scholar
• ElgieRMorselliPLSocial functioning in bipolar patients: the perception and perspective of patients, relatives and advocacy organizations – a reviewBipolar Disord200791445717391357
   PubMed Web of Science ®Google Scholar
• EndicottJSpitzerRLFleissJLThe global assessment scale. A procedure for measuring overall severity of psychiatric disturbanceArch Gen Psychiatry19763376671938196
   PubMed Web of Science ®Google Scholar
• European Medicines AgencyNote for guidance on clinical investigation of medical products in the treatment and prevention of bipolar disorder2007
   Google Scholar
• GoodwinGMEvidence-based guidelines for treating bipolar disorder: recommendations from the British Association for PsychopharmacologyJ Psychopharmacol20031714973 discussion 14712870562
   PubMed Web of Science ®Google Scholar
• GrunzeHKasperSGoodwinGThe World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of ManiaWorld J Biol Psychiatry2003451312582971
   PubMed Web of Science ®Google Scholar
• [NIMH] National Institute of Mental HealthGuyWAIMS, Abnormal Involuntary Movement ScaleECDEU Assessment Manual of Psychopharmacology Review1976Rockville, USANIMH
   Google Scholar
• KrishnanKRPsychiatric and medical comorbidities of bipolar disorderPsychosom Med2005671815673617
   PubMed Web of Science ®Google Scholar
• LeuchtSPitschel-WalzGEngelRRAmisulpride, an unusual “atypical” antipsychotic: a meta-analysis of randomized controlled trialsAm J Psychiatry20021591809011823257
   PubMed Web of Science ®Google Scholar
• LevinFRHennessyGBipolar disorder and substance abuseBiol Psychiatry2004567384815556118
   PubMed Web of Science ®Google Scholar
• LichtRWLimitations in randomised controlled trials evaluating drug effects in maniaEur Arch Psychiatry Clin Neurosci2001251Suppl 2II667111824841
   PubMed Web of Science ®Google Scholar
• LichtRWLimits of the applicability and generalizability of drug trials in maniaBipolar Disord20024Suppl 166812479682
   PubMed Web of Science ®Google Scholar
• McIntyreRSBrecherMPaulssonBQuetiapine or haloperidol as monotherapy for bipolar mania – a 12-week, double-blind, randomised, parallel-group, placebo-controlled trialEur Neuropsychopharmacol2005155738516139175
   PubMed Web of Science ®Google Scholar
• MontgomerySADopaminergic deficit and the role of amisulpride in the treatment of mood disordersInt Clin Psychopharmacol200217Suppl 4S915 discussion S16–712685917
   PubMed Web of Science ®Google Scholar
• MontgomerySAÅsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry19791343829444788
   PubMed Web of Science ®Google Scholar
• Muller-OerlinghausenBRetzowAHennFAValproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study GroupJ Clin Psychopharmacol20002019520310770458
   PubMed Web of Science ®Google Scholar
• OverallJGorhamDThe Brief Psychiatric Rating ScalePsychol Reports196210799812
   Web of Science ®Google Scholar
• PeuskensJMollerHJPuechAAmisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidoneEur Neuropsychopharmacol2002123051012126869
   PubMed Web of Science ®Google Scholar
• PiniSde QueirozVPagninDPrevalence and burden of bipolar disorders in European countriesEur Neuropsychopharmacol2005154253415935623
   PubMed Web of Science ®Google Scholar
• ReinWCoulouvratCDondey-NouvelLSafety profile of amisulpride in short- and long-term useActa Psychiatr Scand Suppl200040023710823308
   PubMedGoogle Scholar
• SachsGChengappaKNSuppesTQuetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled studyBipolar Disord200462132315117400
   PubMed Web of Science ®Google Scholar
• SachsGSGrossmanFGhaemiSNCombination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safetyAm J Psychiatry200215911465412091192
   PubMed Web of Science ®Google Scholar
• ScherkHPajonkFGLeuchtSSecond-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trialsArch Gen Psychiatry2007644425517404121
   PubMed Web of Science ®Google Scholar
• SegalJBerkMBrookSRisperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trialClin Neuropharmacol199821176809617509
   PubMed Web of Science ®Google Scholar
• ShiLNamjoshiMAZhangFOlanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work statusInt Clin Psychopharmacol2002172273712177585
   PubMed Web of Science ®Google Scholar
• SimpsonGAngusJA rating scale for extrapyramidal symptomsActa Psychiatr Scand1970451119
   Google Scholar
• SmithLACorneliusVWarnockAPharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trialsBipolar Disord200795516017845269
   PubMed Web of Science ®Google Scholar
• SmulevichABKhannaSEerdekensMAcute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidolEur Neuropsychopharmacol200515758415572276
   PubMed Web of Science ®Google Scholar
• SpearingMKPostRMLeverichGSModification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BPPsychiatry Res199773159719481807
   PubMed Web of Science ®Google Scholar
• TohenMChengappaKNSuppesTEfficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapyArch Gen Psychiatry20025962911779284
   PubMed Web of Science ®Google Scholar
• TohenMGoldbergJFGonzalez-Pinto ArrillagaAMA 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute maniaArch Gen Psychiatry20036012182614662554
   PubMed Web of Science ®Google Scholar
• VietaEBourinMSanchezREffectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trialBr J Psychiatry2005a1872354216135860
   PubMed Web of Science ®Google Scholar
• VietaECarneXThe use of placebo in clinical trials on bipolar disorder: a new approach for an old debatePsychother Psychosomatics2005741016
   PubMed Web of Science ®Google Scholar
• VietaERosSGoikoleaJMAn open-label study of amisulpride in the treatment of maniaJ Clin Psychiatry2005b66575815889942
   PubMed Web of Science ®Google Scholar
• YathamLNPaulssonBMullenJQuetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar maniaJ Clin Psychopharmacol20042459960615538120
   PubMed Web of Science ®Google Scholar
• YoungRCBiggsJTZieglerVEA rating scale for mania: reliability, validity and sensitivityBr J Psychiatry197813342935728692
   PubMed Web of Science ®Google Scholar